These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25368217)

  • 41. [Editorial comment: Theme issue on diabetology].
    Jermendy G
    Orv Hetil; 2011 Nov; 152(48):1915. PubMed ID: 22071293
    [No Abstract]   [Full Text] [Related]  

  • 42. Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
    Rensing KL; Reuwer AQ; Arsenault BJ; von der Thüsen JH; Hoekstra JB; Kastelein JJ; Twickler TB
    Diabetes Obes Metab; 2011 Dec; 13(12):1073-87. PubMed ID: 21736687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helping patients make sense of the risks of taking GLP-1 agonists.
    Montori VM
    BMJ; 2013 Jun; 346():f3692. PubMed ID: 23751906
    [No Abstract]   [Full Text] [Related]  

  • 44. Top 10 facts you should know about diabetes.
    Call RJ; Wofford MR; Riche DM
    J Miss State Med Assoc; 2012 Aug; 53(8):275-7. PubMed ID: 23094391
    [No Abstract]   [Full Text] [Related]  

  • 45. ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use.
    Lombard L; Distiller L; Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):357-8. PubMed ID: 23091824
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
    Marx N
    Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
    Martin S
    Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
    [No Abstract]   [Full Text] [Related]  

  • 48. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 49. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardioprotection by acarbose--pro].
    Breuer HW
    Dtsch Med Wochenschr; 2004 May; 129(20):1155. PubMed ID: 15143459
    [No Abstract]   [Full Text] [Related]  

  • 51. Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
    Dai Y; Dai D; Mercanti F; Ding Z; Wang X; Mehta JL
    Acta Diabetol; 2013 Dec; 50(6):827-35. PubMed ID: 23824323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes.
    Miao Y; Smink PA; de Zeeuw D; Lambers Heerspink HJ
    Clin Chem; 2011 Feb; 57(2):186-95. PubMed ID: 21159899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease prevention.
    Muzurović E; Dragnić S; Medenica S; Smolović B; Bulajić P; Mikhailidis DP
    J Diabetes Complications; 2020 Aug; 34(8):107619. PubMed ID: 32499116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cardioprotection by acarbose--contra].
    Kaiser T; Sawicki PT
    Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cardiovascular disease in diabetic patients: risk factors, clinical history and prevention].
    Avogaro A
    G Ital Cardiol (Rome); 2016 Dec; 17(12 Suppl 2):3S-12. PubMed ID: 28151516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects.
    Shubrook JH
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):Sii-1. PubMed ID: 21928545
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiologists and the management of blood sugar: a Chinese perspective.
    Hu DY; Guo YF
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):509. PubMed ID: 18719711
    [No Abstract]   [Full Text] [Related]  

  • 58. [Glitazone - mailing no 1. In response to DMW 49/2007].
    Traut V
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261; author reply 262-3. PubMed ID: 18236356
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rapid postprandial blood glucose control: indications for better cardiovascular protection in the diabetic patient].
    MMW Fortschr Med; 2012 Apr; 154(6):34-5. PubMed ID: 22642028
    [No Abstract]   [Full Text] [Related]  

  • 60. [Anti-diabetic therapy and cardiovascular risk].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.